OSBPL3 and breast cancer: In summary, our findings suggested that miR-181a-5p enhanced tamoxifen chemosensitivity in MCF7 BC cells through OSBPL3 suppression via RAS/MAPK and PI3K/AKT signaling axis inhibition.